JPRN-jRCT2080220892未知2 期
Efficacy and Safety of SK-0403 in Patients with Type 2 Diabetes
适应症
试验速览
- 阶段
- 2 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •Patients with type 2 diabetes who have inadequate glycemic control on diet therapy or diet plus exercise therapy
- •HbA1C of >=6.5%, but < 10.0% measured during the run-in period
排除标准
- •Patients with type 1 diabetes mellitus
- •Patients require insulin or oral antidiabetic drug therapy
- •Patients with, or a history of, clinically significant cardiac, renal, hepatic, pulmonary, pancreatic and macrovascular disease
- •Patients have a known allergy or hypersensitivity to voglibose
研究者
相似试验
已完成
3 期
ong-term safety and efficacy of TK-023 in Patients with Severe Dementia of the Alzheimer's TypeDementia of the Alzheimer's typeJPRN-jRCT2080224612TEIKOKU SEIYAKU Co., LTD.70
未知
3 期
A clinical pharmacological study of SK-0403Type 2 diabetes mellitusJPRN-jRCT2080221260SANWA KAGAKU KENKYUSHO CO.,LTD.20
招募中
3 期
Study of Out of Specification for TisagenlecleucelPediatric/young adult patients with r/r pALL and adult patients with r/r LBCL (including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma) for Part 1, and r/r ALL and r/r NHL for Part 2.JPRN-jRCT1080224903ovartis Pharma. K.K.200
撤回
2 期
The safety and efficacy of STC3141 in patient with COVID-19 Acute Respiratory Distress SyndromeCOVID-19 infectionInfection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12620000588998Grand Medical Pty Ltd160
未知
3 期
Efficacy and Long-Term Safety of SK-0403 as Monotherapy in Patients with Type 2 DiabetesType 2 Diabetes MellitusJPRN-jRCT2080220750Kowa Co., Ltd.